CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 45 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $12,040,000 | +51.9% | 356,234 | +5.1% | 0.00% | +100.0% |
| Q1 2021 | $7,925,000 | -22.7% | 338,829 | -4.8% | 0.00% | -50.0% |
| Q4 2020 | $10,248,000 | +39.4% | 355,904 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $7,350,000 | -26.2% | 362,771 | +9.5% | 0.00% | 0.0% |
| Q2 2020 | $9,954,000 | +36.7% | 331,241 | +43.0% | 0.00% | 0.0% |
| Q1 2020 | $7,283,000 | -15.0% | 231,717 | +27.4% | 0.00% | 0.0% |
| Q4 2019 | $8,568,000 | +753.4% | 181,873 | +16.9% | 0.00% | – |
| Q3 2019 | $1,004,000 | -44.1% | 155,528 | +6.3% | 0.00% | – |
| Q2 2019 | $1,797,000 | +2.2% | 146,358 | +12.7% | 0.00% | – |
| Q1 2019 | $1,759,000 | +762.3% | 129,810 | +154.5% | 0.00% | – |
| Q4 2018 | $204,000 | -33.3% | 51,008 | +12.4% | 0.00% | – |
| Q3 2018 | $306,000 | – | 45,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $45,338,000 | 33.03% |
| Ponoi Management, LLC | 1,880,623 | $54,162,000 | 30.99% |
| VR Adviser, LLC | 4,016,873 | $115,686,000 | 17.01% |
| Column Group LLC | 2,626,631 | $75,647,000 | 6.86% |
| COMMODORE CAPITAL LP | 423,708 | $12,203,000 | 6.64% |
| GREAT POINT PARTNERS LLC | 1,024,800 | $29,514,000 | 4.79% |
| Venrock Management V, LLC | 1,557,276 | $44,850,000 | 4.23% |
| Ghost Tree Capital, LLC | 625,000 | $18,000,000 | 4.01% |
| Euclidean Capital LLC | 554,325 | $15,965,000 | 3.38% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 737,406 | $21,237,000 | 3.07% |